title: Gene transfer to the outflow tract.
abstract: Elevated intraocular pressure is the primary cause of open angle glaucoma. Outflow resistance exists within the trabecular meshwork but also at the level of Schlemm's canal and further downstream within the outflow system. Viral vectors allow to take advantage of naturally evolved, highly efficient mechanisms of gene transfer, a process that is termed transduction. They can be produced at biosafety level 2 in the lab using protocols that have evolved considerably over the last 15-20 years. Applied by an intracameral bolus, vectors follow conventional as well as uveoscleral outflow pathways. They may affect other structures in the anterior chamber depending on their transduction kinetics which can vary among species when using the same vector. Not all vectors can express long-term, a desirable feature to address the chronicity of glaucoma. Vectors that integrate into the genome of the target cell can achieve transgene function for the life of the transduced cell but are mutagenic by definition. The most prominent long-term expressing vector systems are based on lentiviruses that are derived from HIV, FIV, or EIAV. Safety considerations make non-primate lentiviral vector systems easier to work with as they are not derived from human pathogens. Non-integrating vectors are subject to degradation and attritional dilution during cell division. Lentiviral vectors have to integrate in order to express while adeno-associated viral vectors (AAV) often persist as intracellular concatemers but may also integrate. Adeno- and herpes viral vectors do not integrate and earlier generation systems might be relatively immunogenic. Nonviral methods of gene transfer are termed transfection with few restrictions of transgene size and type but often a much less efficient gene transfer that is also short-lived. Traditional gene transfer delivers exons while some vectors (lentiviral, herpes and adenoviral) allow transfer of entire genes that include introns. Recent insights have highlighted the role of non-coding RNA, most prominently, siRNA, miRNA and lncRNA. SiRNA is highly specific, miRNA is less specific, while lncRNA uses highly complex mechanisms that involve secondary structures and intergenic, intronic, overlapping, antisense, and bidirectional location. Several promising preclinical studies have targeted the RhoA or the prostaglandin pathway or modified the extracellular matrix. TGF-β and glaucoma myocilin mutants have been transduced to elevate the intraocular pressure in glaucoma models. Cell based therapies have started to show first promise. Past approaches have focused on the trabecular meshwork and the inner wall of Schlemm's canal while new strategies are concerned with modification of outflow tract elements that are downstream of the trabecular meshwork.
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, USA.
authors.forename: Yalong
authors.initials: Y
authors.lastname: Dang
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, USA.
authors.forename: Ralitsa
authors.initials: R
authors.lastname: Loewen
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, USA; New Jersey Medical School, Rutgers State University of New Jersey, Newark, NJ 07103, USA.
authors.forename: Hardik A
authors.initials: HA
authors.lastname: Parikh
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, USA.
authors.forename: Pritha
authors.initials: P
authors.lastname: Roy
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, USA. Electronic address: Loewen.nils@gmail.com.
authors.forename: Nils A
authors.initials: NA
authors.lastname: Loewen
mesh_terms: D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000502:physiology; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005902:Glaucoma, Open-Angle / Q000235:genetics / Q000628:therapy*; D006801:Humans; D014129:Trabecular Meshwork / Q000378:metabolism*; D019076:Transgenes / Q000235:genetics
keywords: Gene therapy; Glaucoma; Intraocular pressure; Outflow tract; Trabecular meshwork